Cepheid Gains IVDR CE Mark for Respiratory Panel
Sunnyvale, California, United States, November 10, 2026 Cepheid, a Danaher company specializing in molecular diagnostics, has achieved CE marking...
Danaher
Advertisement
Cepheid Wins FDA Clearance for Hemorrhagic Fever Panel
Sunnyvale, California, USA, November 3, 2026 Cepheid, a Danaher company and a global leader in molecular diagnostics, has announced...
SK bioscience Advances RSV Antibody Clinical Development
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
Genedata Advances AI Biomarker Discovery in Alzheimer’s Research
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
Masimo Earns FDA 510(k) for Pediatric Brain Monitoring
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
Advertisement
